Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Real Time Quote from BATS)

$6.75 USD

6.75
79,718

-0.16 (-2.32%)

Updated Jun 11, 2024 10:28 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Universal Health's (UHS) Q1 Earnings: What is in Store?

by Zacks Equity Research

Universal Health's (UHS) first-quarter results are likely to reflect better revenues, partially offset by the COVID-19 impact.

HCA Healthcare's (HCA) Earnings Miss in Q1, Decrease Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) Q1 earnings take a hit from the coronavirus outbreak inducing lower patient volumes.

    HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?

    by Zacks Equity Research

    HCA Healthcare's (HCA) Q1 results are likely to reflect weak volumes from the coronavirus effect.

    MEDNAX Plunges More Than 54% YTD: Will the Stock Rebound?

    by Zacks Equity Research

    Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds high prospects to revive its fortunes by virtue of its solid fundamentals.

    MEDNAX Provides Updates Related to Coronavirus Pandemic

    by Zacks Equity Research

    MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic.

    Universal Health Plunges 31.4% YTD: Will It Bounce Back?

    by Zacks Equity Research

    Even though Universal Health (UHS) suffers the COVID-19 impact on global economy, it holds potential to stage a comeback by virtue of its solid fundamentals.

    HCA Healthcare, Google Cloud Tie Up Amid Coronavirus Woes

    by Zacks Equity Research

    HCA Healthcare (HCA) partners Google Cloud and SADA for the COVID-19 National Response Portal, a platform to provide real-time COVID-19 updates.

    Select Medical Revokes Full-Year View Amid Coronavirus Blues

    by Zacks Equity Research

    Plagued by business uncertainty from the coronavirus outbreak, Select Medical (SEM) ditches its 2020 earnings guidance.

    HCA Healthcare Makes Cost-Control Efforts Amid Coronavirus Woes

    by Zacks Equity Research

    HCA Healthcare (HCA) trims headcount to contain costs as its revenues are under pressure.

    MEDNAX Withdraws Q1 & 2020 Guidance Due to Coronavirus Woes

    by Zacks Equity Research

    MEDNAX (MD) takes back its first-quarter 2020 and preliminary full-year outlook due to the COVID-19 effect.

      Mednax (MD) Down 55.2% Since Last Earnings Report: Can It Rebound?

      by Zacks Equity Research

      Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Community Health (CYH) Hits 52-Week High on Solid Q4 Results

      by Zacks Equity Research

      Community Health (CYH) reaches a 52-week high in Friday's trading session, backed by its strong fourth-quarter earnings performance.

      MEDNAX (MD) Q4 Earnings and Revenues Surpass Estimates

      by Zacks Equity Research

      Mednax's (MD) Q4 results reflect growth in same unit revenues and lower general and administrative expenses.

      Earnings Preview: Mednax (MD) Q4 Earnings Expected to Decline

      by Zacks Equity Research

      Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Why Should You Retain MEDNAX (MD) Stock in Your Portfolio?

      by Zacks Equity Research

      Riding high on its rising revenue stream and inorganic growth profile, MEDNAX (MD) holds potential to benefit its investors.

      HCA Healthcare Acquires Valify to Rein in Medical Costs

      by Zacks Equity Research

      HCA Healthcare (HCA) completes the buyout of technology company Valify to identify opportunities for reducing expenses.

      Why Should You Hold HCA Healthcare in Your Portfolio Now?

      by Zacks Equity Research

      Riding high on its growing revenues and a firm capital position, HCA Healthcare (HCA) holds potential to reap benefits for investors.

      MEDNAX Expands Further in Florida With Radiology Affiliation

      by Zacks Equity Research

      MEDNAX (MD) forms an association with Boca Radiology Group to strengthen its radiology business in Florida.

      MEDNAX (MD) Catches Eye: Stock Jumps 8.1%

      by Zacks Equity Research

      MEDNAX (MD) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

      Here's Why Should You Hold MEDNAX (MD) in Your Portfolio

      by Zacks Equity Research

      Riding high on its solid top line as well as strategic buyouts, MEDNAX (MD) holds enough potential to generate returns for investors.

      Why Is Mednax (MD) Up 18.9% Since Last Earnings Report?

      by Zacks Equity Research

      Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      MEDNAX (MD) Ties Up With Homestead to Expand in Florida

      by Zacks Equity Research

      MEDNAX (MD) collaborates with Associated Pediatricians of Homestead to provide clinical services and expand presence in Florida.

      MEDNAX's Ratings Get Affirmed by Moody's, Outlook Negative

      by Zacks Equity Research

      MEDNAX (MD) receives rating affirmations from Moody's. However, the outlook is changed to negative.

        MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y

        by Zacks Equity Research

        MEDNAX's (MD) results reflect escalating expenses in the third quarter.

        Mednax (MD) Q3 Earnings Meet Estimates

        by Zacks Equity Research

        Mednax (MD) delivered earnings and revenue surprises of 0.00% and 1.75%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?